Page last updated: 2024-12-06

cyclobutyrol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyclobutyrol: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyclobutyrol : A hydroxy monocarboxylic acid in which the hydroxy group is geminal to a 1-carboxypropyl group on a cyclohexane ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID72065
CHEMBL ID1697739
CHEBI ID61024
SCHEMBL ID312912
MeSH IDM0041545

Synonyms (43)

Synonym
(rs)-2-(1-hydroxycyclohexyl)buttersaeure
cyclobutyrolum
cyclobutyral
CHEBI:61024 ,
ciclobutirol
jl 130
ciclobutirol [inn-spanish]
alpha-(1-hydroxycyclohexyl)butyric acid
einecs 208-138-5
alpha-ethyl-1-hydroxycyclohexaneacetic acid
1-hydroxy-alpha-ethylcyclohexylacetic acid
cyclobutyrolum [inn-latin]
brn 2209058
cyclobutyrol
cyclohexaneacetic acid, alpha-ethyl-1-hydroxy-
1-cyclohexanol-alpha-butyric acid
cyclobutyrol [inn:dcf]
D07104
512-16-3
cyclobutyrol (inn)
2-(1-hydroxycyclohexyl)butanoic acid
jl-130
CHEMBL1697739
AKOS011684517
8t4l120n6m ,
unii-8t4l120n6m
4-10-00-00049 (beilstein handbook reference)
EPITOPE ID:139985
SCHEMBL312912
.alpha.-ethyl-1-hydroxycyclohexaneacetic acid
cyclobutyrol [who-dd]
cyclobutyrol [inn]
cyclobutyrol [mi]
cyclohexaneacetic acid, .alpha.-ethyl-1-hydroxy-
DTXSID00862084
Q601419
2-(1-hydroxycyclohexyl) butyric acid
DB13493
jl 130; brn 2209058
CS-0066299
HY-118534
EN300-1266341
Z982137530

Research Excerpts

Overview

Cyclobutyrol (CB) is a choleretic agent which also inhibits biliary lipid secretion.

ExcerptReferenceRelevance
"Cyclobutyrol (CB) is a choleretic agent which also inhibits biliary lipid secretion."( Inhibitory action of cyclobutyrol on the secretion of biliary cholesterol and phospholipids.
Coleman, R; Monte, MJ; Parslow, RA, 1990
)
1.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bile therapy drugA drug used in the treatment of bile or liver disorders.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]